Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Steven James Kellner

Steven James Kellner

Head International Research and Development
Mesencell Biotech International Ltd
United Kingdom

Biography

Dr Kellner is now founder and chief scientist of Mesencell Biotech, which focuses on autologous stem cell and dendritic cell treatments in the Middle East and Northern Africa, co-founder and chief scientist of Med Cell Bahamas with a government licence for stem cell treatments in the Bahamas, co-founder and chief scientist of Med Cell International in the USA and co-founder, board member and chief scientist of Med Cell plc responsible for worldwide research projects and clinical trials for diseases such as Alzheimer Disease, Parkinson Disease, Diabetes T1 and T2 and osteoarthritis. Apart from his main research focus into neurological disease (Alzheimer and Parkinson Disease and retinal disease) Dr Kellner mentors young biotech start-up companies and actively seeks and finds collaboration with other research institutes and local governments. Dr Kellner is also Editor in Chief of Journal of Stem Cell Research & Therapeutics and the Journal of Advance Research on Alzheimers & Parkinsons Disease (ARAP) and Editor of Archives in Neurology & Neuroscience.

Research Interest

Mesenchymal Stem Cells, Dendritic Cells, Biomarkers